GLP-1 SM 50mg Peptides
Designed for disciplined research, this vial delivers the steadiness and clarity your protocols require.
GLP-1 SM is presented as a lyophilized research peptide vial for laboratory applications, formulated as a stable powder for controlled handling. This single-vial format contains a total strength of 50mg, offering a dependable option for investigations focused on receptor engagement and signaling related to the glucagon-like peptide-1 pathway. The presentation is clean and streamlined to support precise technique, consistent measurements, and reproducible outcomes under validated lab methods.
- Each vial contains 50mg of GLP-1 SM, supporting in vitro exploration of glucagon-like peptide-1 receptor mechanisms, assay standardization, binding evaluations, and comparative screening in controlled research settings.
As a non-edible research material, this lyophilized format is engineered for professional laboratory workflows. The solid-state presentation helps minimize variability introduced by transport or ambient conditions, enabling careful reconstitution and accurate aliquoting per institutional SOPs. Researchers value the concise, single-vial configuration for method development, cell-based studies, and analytical work where consistency, clarity of handling, and lot-to-lot reliability are essential. The focus is on measured performance inside the lab - not claims - allowing teams to draw conclusions from well-controlled, well-documented procedures.
Peptide Scientific Labs operates with a quality-first mindset. Our materials are produced and filled in the USA, with rigorous lot control, documented chain of custody, and third-party testing for identity and purity. Each batch is released only after meeting strict acceptance criteria aligned with our internal quality system, supporting traceability and confidence in your results. We emphasize careful sourcing, controlled environments, and professional packaging to safeguard integrity from production through delivery. For researchers who require dependable inputs, this GLP-1 SM vial reflects a disciplined approach to peptide quality and transparency.
Ingredients: GLP-1 SM (lyophilized powder). For laboratory research use only. Not for human or veterinary use. Handle in accordance with institutional guidelines and applicable regulations.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
This Product Contains
